Search Results - "HIBBS, Martin J."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Discovery and Biochemical Characterization of Plasmodium Thioredoxin Reductase Inhibitors from an Antimalarial Set by Theobald, Andrew J, Caballero, Iván, Coma, Isabel, Colmenarejo, Gonzalo, Cid, Concepcion, Gamo, Francisco-Javier, Hibbs, Martin J, Bass, Amy L, Thomas, Daniel A

    Published in Biochemistry (Easton) (12-06-2012)
    “…Plasmodium falciparum is the most prevalent and deadly species of the human malaria parasites, and thioredoxin reductase (TrxR) is an enzyme involved in the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase by Jarvest, Richard L., Erskine, Symon G., Forrest, Andrew K., Fosberry, Andrew P., Hibbs, Martin J., Jones, Joanna J., O’Hanlon, Peter J., Sheppard, Robert J., Worby, Angela

    Published in Bioorganic & medicinal chemistry letters (02-05-2005)
    “…High throughput screening of Staphylococcus aureus phenylalanyl tRNA synthetase (FRS) identified an ethanolamine as a sub-micromolar hit. Optimisation studies…”
    Get full text
    Journal Article
  6. 6

    Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat by Pratt, JR, Hibbs, MJ, Laver, AJ, Smith, RA, Sacks, SH

    Published in The American journal of pathology (01-12-1996)
    “…Complement is both an effector of the humoral immune response and a stimulator of leukocyte activation. To examine the influence of complement on the allograft…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730) by Smith, 3rd, E F, Griswold, D E, Egan, J W, Hillegass, L M, Smith, R A, Hibbs, M J, Gagnon, R C

    Published in European journal of pharmacology (04-06-1993)
    “…This study was designed to evaluate the cardioprotective effects of a solubilized human complement receptor, sCR1, in the rat subjected to myocardial…”
    Get more information
    Journal Article